ArticleCancers2022

CD20 Expression as a Possible Novel Prognostic Marker in CLL: Application of EuroFlow Standardization Technique and Normalization Procedures in Flow Cytometric Expression Analysis.

Anke Schilhabel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.